Infinium Pharmachem IPO listing price is ₹ 141.50, issue price is ₹ 135.00, and currently trading at ₹ 294.05 as on June 12, 2025. Infinium Pharmachem IPO performance is show below with latest CAGR.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Infinium Pharmachem IPO is a Fixed Price listing on NSE EMERGE exchange. The company is based in Anand and caters to Pharmaceutical sector. Swastika Investmart is the merchant banker of Infinium Pharmachem IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 17th February 2023.
Infinium Pharmachem IPO offer price is ₹ 135.00 and got listed at ₹ 141.50. Read Infinium Pharmachem IPO details mentioned above.The IPO of Infinium Pharmachem Limited was listed on 17th April 2023. As of today, Infinium Pharmachem IPO is trading at ₹ 294.05, compared to the previous day’s close of ₹ 306.90. Read the report above for detailed IPO performance.
The issue price of Infinium Pharmachem IPO was ₹ 135.00 per equity share.
Infinium Pharmachem IPO was listed at ₹141.50 on the stock exchange on 17th April 2023. The listing price is the price at which the shares started trading on the stock exchange after the IPO was completed.
As of June 12, 2025, the current market price of Infinium Pharmachem IPO is ₹ 294.05.
The 52-week high for Infinium Pharmachem IPO is [●], while the 52-week low is [●]. These figures reflect the stock’s highest and lowest trading prices in the past one year from the current date.
The Infinium Pharmachem IPO listed at ₹ 141.50 against the issue price of ₹ 135.00 per equity share, showing a listing day gain/loss of 6.5 (4.81%) , calculated by comparing the listing price to the issue price on the first day of trading.
The Infinium Pharmachem IPO stock moved from its listing price of ₹ 141.50 to the current price of ₹294.05 per equity share, reflecting a change of 107.81% per share, calculated by subtracting the listing price from the current market price (CMP) as of today.
Based on Infinium Pharmachem IPO issue date of 17th April 2023 and CMP of ₹294.05, the estimated CAGR is approximately 43.22%.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Infinium Pharmachem IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Infinium Pharmachem Financial Review Page
Merchant Banker(s) of Infinium Pharmachem IPO: Swastika Investmart Limited
Infinium Pharmachem IPO subscription was 1.84 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Infinium Pharmachem IPO listed at a listing price of 141.50 against the offer price of 135.00.
The current market price of Infinium Pharmachem is 294.05.
Why Us?